Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AD293 |
Human embryonic kidney cell line (derivat of HEK293 producing the adenovirus E1 gene in trans) | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | K2 Transfection System | publication | S. Wohlfart et al., Am. J. Med. Genet. Part A, 2015, 170A: 249-253, DOI 10.1002/ajmg.a.37412 | |||
AD293 |
Human embryonic kidney cell line (derivat of HEK293 producing the adenovirus E1 gene in trans) | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | K2 Transfection System | publication | S. Wohlfart et al., Clin. Genetics, 2019, 95: 427–432, DOI: 10.1111/cge.13503 | Link | ||
AD293 |
Human embryonic kidney cell line (derivative of HEK293 producing the adenovirus E1 gene in trans) | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | publication | M. Dumitrescu et al., Int. J. Mol. Sci., 2020, 21, 6011, doi:10.3390/ijms21176011 | Link | |||
AD293 |
Human embryonic kidney cell line (derivat of HEK293 producing the adenovirus E1 gene in trans) | Human | urinary system | cell line | adherent | plasmid | virusproduction | K2 Transfection System | application note | ![]() |
|||
AD293 |
Human embryonic kidney cell line (derivative of HEK293 producing the adenovirus E1 gene in trans) | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | publication | M. Dumitrescu et al., J. Vis. Exp., 2021, 172: e61691, doi:10.3791/61691 | Link | |||
ARPE-19 |
Human ephitelial retina cells | ATCC CRL-2302 | Human | sensory organs | unknown | adherent | plasmid | cotransfection (plasmid/plasmid) | K2 Transfection System | application note | ![]() |
||
ARPE-19 |
Human ephitelial retina cells | ATCC CRL-2302 | Human | sensory organs | unknown | adherent | plasmid | cotransfection (plasmid/plasmid) | K2 Transfection System | application note | ![]() |
||
BEAS-2B |
Human bronchial epithelial cell line | ATCC CRL-9609 | Human | respiratory system | cell line | adherent | plasmid | K2 Transfection System | publication | P. C. Shivalingappa et al., Antioxidants & Redox Signaling, 2016, 24 (4): 186, DOI: 10.1089/ars.2015.6367 | Link | ||
BeWo |
Human placenta choriocarcinoma cell line | ATCC CCL-98 | Human | respiratory system | cell line | adherent | plasmid | K2 Transfection System | application note | ![]() |
|||
BxPC3 |
Human pancreatic adenocarcinoma cell line | ATCC CRL-1687 | Human | digestive organs | cell line | adherent | plasmid | K2 Transfection System | publication | A. Carozzoa et al., Mol. Pharmacology, 2019, 115444, DOI: 10.1124/mol.118.115444 | Link | ||
BxPC3 |
Human pancreatic adenocarcinoma cell line | ATCC CRL-1687 | Human | digestive organs | cell line | adherent | plasmid | stable transfection | K2 Transfection System | publication | A. Carozzoa et al., Mol. Pharmacology, 2019, 115444, DOI: 10.1124/mol.118.115444 | Link | |
BxPC3 |
Human pancreatic adenocarcinoma cell line | ATCC CRL-1687 | Human | digestive organs | cell line | adherent | plasmid | K2 Transfection System | application note | ![]() |
|||
Caco-2 |
Human colon adenocarcinoma cell line | ATCC HTB-37 | Human | digestive organs | cell line | adherent | plasmid | K2 Transfection System | application note | ![]() |
|||
Calu-1 |
Human lung epidermoid carcinoma cell line | ATCC HTB-54 | Human | respiratory system | cell line | adherent | plasmid | K2 Transfection System | application note | ![]() |
|||
D54 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | siRNA | RNA-Interference | K2 Transfection System | publication | P. D’Arrigo et al., Cell Death Discovery, 2019, 5:137, doi.org/10.1038/s41420-019-0216-0 | Link | ||
D54 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | plasmid | cotransfection (plasmid/siRNA) | K2 Transfection System | publication | P. D’Arrigo et al., Cell Death Discovery, 2019, 5:137, doi.org/10.1038/s41420-019-0216-0 | Link | ||
D54 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | plasmid | K2 Transfection System | publication | P. D’Arrigo et al., Cell Death Discovery, 2019, 5:137, doi.org/10.1038/s41420-019-0216-0 | Link | |||
D54 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | plasmid | K2 Transfection System | publication | P. D’Arrigo et al., Oncotarget, 2017, 8 (40): 68291-68304 | Link | |||
D54 |
Human brain glioblastoma cell line | Human | brain | cell line | adherent | siRNA | cotransfection (plasmid/siRNA) | K2 Transfection System | publication | P. D’Arrigo et al., Cell Death Discovery, 2019, 5:137, doi.org/10.1038/s41420-019-0216-0 | Link | ||
DLD-1 |
Human colon adenocarcinoma cells | ATCC CCL-221 | Human | digestive organs | cell line | adherent | plasmid | K2 Transfection System | application note | ![]() |
|||
EFO-27 |
Human ovary adenocarcinoma cell line (cisplatin resistant) | Human | genital tract | cell line | adherent | plasmid | stable transfection | K2 Transfection System | application note | ![]() |
|||
EFO-27 |
Human ovary adenocarcinoma cell line (cisplatin resistant) | Human | genital tract | cell line | adherent | plasmid | K2 Transfection System | application note | ![]() |
||||
EFO-27 |
Human ovary adenocarcinoma cell line (cisplatin resistant) | Human | genital tract | cell line | adherent | plasmid | K2 Transfection System | publication | S. Dilruba et al., Cells, 2020, 9: 515, doi:10.3390/cells9020515 | Link | |||
F26IIB |
Human cells derived from a dyskeratosis congenita patient | Human | unknown | unknown | plasmid | K2 Transfection System | publication | L. Iarriccio et al., PLOS ONE, 2015, DOI:10.1371/journal.pone.0142980 | Link | ||||
FLYRD18 |
Human fibrosarcoma retrovirus packaging cell line | Human | unknown | cell line | adherent | plasmid | K2 Transfection System | application note | ![]() |